SABBY 13G VTGN 5.13.16

Company

Vistagen Therapeutics, Inc.

Filed

May 13, 2016

Accession Number

0001535610-16-000150

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →